Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | -1.21% | 81.34 | 0.7% | $984.93m | |
| PFE | Pfizer Inc. | -2.91% | 34.68 | 0.9% | $941.81m | |
| ABBV | AbbVie, Inc. | -1.94% | 93.12 | 2.3% | $934.45m | |
| JNJ | Johnson & Johnson | -2.01% | 145.99 | 0.7% | $926.74m | |
| BMY | Bristol-Myers Squibb Co. | -2.55% | 63.96 | 1.0% | $765.27m | |
| LLY | Eli Lilly & Co. | -2.73% | 138.16 | 1.1% | $477.06m | |
| NVS | Novartis AG | -6.92% | 90.06 | 0.2% | $174.74m | |
| GSK | GlaxoSmithKline Plc | -2.69% | 41.92 | 0.2% | $163.07m | |
| AZN | AstraZeneca Plc | -5.14% | 47.59 | 1.2% | $150.12m | |
| BHC | Bausch Health Cos., Inc. | -1.85% | 26.01 | 0.0% | $96.00m | |
| RETA | Reata Pharmaceuticals, Inc. | -7.06% | 196.23 | 3.4% | $87.55m | |
| SNY | Sanofi | -1.99% | 49.84 | 0.2% | $82.42m | |
| GNPX | Genprex, Inc. | 13.13% | 6.03 | 0.0% | $80.63m | |
| NVO | Novo Nordisk A/S | -3.99% | 61.31 | 0.1% | $76.21m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -1.76% | 44.54 | 0.0% | $55.85m |
Company Profile
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Crestwood, KY.